ImmunityBio, Inc. (IBRX) › Cost of RevenueImmunityBio, Inc. (IBRX) — Cost of RevenueAnnual figures by fiscal year, from SEC filings.2022: $02023: $02024: $02025: $753.0K$753.0K2022Cost of Revenue (USD)2025Fiscal YearCost of RevenueChange YoY2025$753.0K—2024$0—2023$0—2022$0—Other metrics: RevenueGross ProfitOperating IncomeNet IncomeEPS (Diluted)Total AssetsTotal LiabilitiesShareholders' EquityCash & EquivalentsOperating Cash FlowCapital ExpendituresShares OutstandingDividends Per Share